Enlaces de acceso:
CONTENIDO
Destacados
-
A Versatile and Practical Synthesis toward the Development of Novel HIV-1 Integrase Inhibitors
Rinaldi, M., C. Tintori, L. Franchi, G. Vignaroli, A. Innitzer, S. Massa, J. A. Esté, E. Gonzalo, F. Christ, Z. Debyser, and M. BottaChemMedChem:n/a-n/a.
-
Beta5 integrin is the major contributor to the alphav integrin-mediated blockade of HIV-1 replication
Ballana, E., E. Pauls, F. Perron-Sierra, B. Clotet, G. Tucker, and J. A. EsteJournal of Immunology 186:464-470.
-
Diarylpyrimidine-Dihydrobenzyloxopyrimidine Hybrids: New, Wide-Spectrum Anti-HIV-1
Rotili, D., D. Tarantino, M. Artico, E. Gonzalez-Ortega, B. Clotet, J. A. Esté, G. Maga, and A. MaiJournal of Medicinal Chemistry
-
ADS-J1 inhibits HIV-1 entry by interacting with gp120 and does not block the fusion-active gp41 core formation
Gonzalez-Ortega, E., M.-P. Mena, M. Permanyer, E. Ballana, B. Clotet, and J. A. EsteAntimicrobial Agents Chemotherapy 54:4487-4492
